Dialectic Capital Management’s Kite Pharma, Inc. KITE Stock Holding History

Dialectic Capital Management’s Portfolio KITE Stock Details KITE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-85,000	Closed	-$3.81M	–	103
2016 Q4	$3.81M	Buy	85,000 +35,000	+70%	+$1.72M	2.14%	15
2016 Q3	$2.79M	Buy	50,000 +40,000	+400%	+$2.23M	1.74%	19
2016 Q2	$500K	Buy	+10,000	New	+$491K	0.17%	82
2016 Q1	–	Sell	-35,000	Closed	-$2.16M	–	162
2015 Q4	$2.16M	Buy	35,000 +20,000	+133%	+$1.41M	0.62%	46
2015 Q3	$835K	Buy	+15,000	New	+$944K	0.27%	101

Other funds holding KITE

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

WCM

Wildcat Capital Management New York $229M AUM 132.65% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Dialectic Capital Management's KITE Position: Q1 2017 in Review

Dialectic Capital Management opened a new position in Kite Pharma, Inc. (KITE) in Q1 2017: 23,000 shares worth $1.8M. The stake represents 1.16% of the portfolio and ranks #25 among its holdings. This is a return to the name: Dialectic Capital Management previously reported a position in KITE as recently as Q3 2015.

Dialectic Capital Management first reported a position in KITE in Q3 2015 and has held it in 2 quarters since. 209 funds tracked by Wall St. Rank hold KITE as of Q1 2017.

Dialectic Capital Management held 23,000 shares of Kite Pharma, Inc. worth $1.8M as of Q1 2017.
Kite Pharma, Inc. was a new Dialectic Capital Management position in Q1 2017.
Kite Pharma, Inc. made up 1.16% of Dialectic Capital Management's portfolio in Q1 2017, its #25 holding.
Dialectic Capital Management first reported a position in Kite Pharma, Inc. in Q3 2015 and has held it in 2 quarters since.
209 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q1 2017.

Based on Dialectic Capital Management's 13F filing for Q1 2017, filed 11 May 2017.